Updated on 6 July 2026
Reconstruction In vitro of Mammalian Oogenesis
Associate Professor at University of Teramo
teramo, Italy
About
Female in vitro gametogenesis (IVG) has recently undergone a conceptual revolution following the successful generation of functional oocytes in mouse models from pluripotent stem cell-derived primordial germ cell-like cells (PGCLCs). However, despite these major advances, translation toward human IVG remains extremely limited because the developmental mechanisms governing ovarian niche formation, meiotic progression, and germ-somatic interactions remain poorly understood outside murine systems. The project addresses this critical gap by proposing the large animal fetal ovary, sheep in our skills, as an intermediate translational model bridging murine developmental biology and human reproductive medicine. The developmental information generated from ovarian progression will guide the engineering of permissive ovarian niches capable of supporting human PGCLC meiotic progression and developmental competence.
Similar opportunities
Project cooperation
Human Reproduction, Development & Stem Cell Biology: From Genetics to Translational Models
- Partner seeks Consortium/Coordinator
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-03: Building public trust and outreach in the life sciences
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
- DESTINATION 1: HORIZON-HLTH-2026-01-STAYHLTH-02: Behavioural interventions as primary prevention for Non-Communicable Diseases (NCDs) among young people
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Rafael Santos
Project Manager at Genetics, Reproduction and Development (GRAD) - VUB
Brussels, Belgium
Project cooperation
EXSELI Health — AI Infrastructure for Emotional & Developmental Care
Matan Bar Sela
Product Lead at MindCET
Tel Aviv, Israel
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-07: Establishing a European network of Centres of Excellence (CoEs) for Advanced Therapies Medicinal Products (ATMPs)
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
- DESTINATION 4: HORIZON-HLTH-2026-01-CARE-01: Public procurement of innovative solutions for improving citizens' access to healthcare through integrated or personalised approaches
- DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-09: Multisectoral approach to tackle chronic non-communicable diseases: implementation research maximising collaboration and coordination with sectors and in settings beyond the healthcare system (GACD)
Justyna Walczuk
MEK2 Research Foundation at MEK2 Research Foundation
Warsaw, Poland